Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer
Marina N. Sharifi(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Kyle T. Helzer(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin Carbone Cancer Center), Xiao X. Wei(Dana-Farber Cancer Institute), Jamie M. Sperger(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Grace C. Blitzer(University of Wisconsin–Madison), Amy K. Taylor(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), David Kosoff(University of Wisconsin–Madison), Katherine R. Kaufmann(University of Wisconsin–Madison), John M. Floberg(University of Wisconsin–Madison), Luke A. Nunamaker(University of Wisconsin–Madison), Charlotte Linebarger(University of Wisconsin–Madison), V. Carreño(University of Wisconsin–Madison), Katharine E. Tippins(University of Wisconsin–Madison)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approach
|Nature|2020|1k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592